Radiation and Your Patient Articles
Twice daily radiation therapy with chemotherapy may improve survival times in patients with some advanced head and neck cancers, a new study confirms.
Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.
Male breast cancer patients are less likely than their female counterparts to receive adjuvant hormone therapy and postlumpectomy radiation.
Pediatric patients are better able to tolerate radiation therapy without anesthesia when video movies are projected on the inside of the machine during treatment.
Combining extracorporeal shock wave (ESW) technique with nanoparticle delivery improves treatment of difficult-to-treat solid tumors, such as anaplastic thyroid cancer.
Weekly journaling with oncology nurse review ensures adherence to skin self-care in women undergoing radiation therapy for breast cancer.
A literature review noted improvements in quality of life after patients were coached and educated following radiotherapy for HPV-associated oropharyngeal cancers.
Deviation from radiation treatment protocol in young children being treated for brain neoplasms was associated with decreased overall survival.
ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.
Absolute risks from radiation therapy for women with breast cancer who continue to smoke could exceed the absolute benefit of the therapy.
Regular infusions of high doses of vitamin C safely increased cancer cell sensitivity to treatment in patients with brain and lung cancers.
Virtual Environment Radiotherapy (VERT) program eases anxiety and improves understanding of radiation therapy for patients with prostate cancer.
Palliative radiotherapy for bone metastases is safe, effective — but controversy persists for single-fraction treatment.
QoL after radical prostatectomy, EBRT, or brachytherapy vs active surveillance for prostate cancer are similar.
Hypofractionated regimen of precision radiotherapy was not inferior to conventional RT in patients with intermediate-risk prostate cancer.
The addition of temozolomide to short-course radiotherapy in elderly patients with glioblastoma was associated with some survival benefit compared with radiotherapy alone.
Health care costs lower for early-stage breast cancer when adjuvant radiation therapy follows evidence-based guidelines.
Use of chemotherapy or vaginal brachytherapy (VBT) may improve survival among patients with early-stage uterine papillary serous carcinoma.
Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.
Treatment with radiation therapy for invasive breast cancer may place East Asian women at a greater risk of developing second primary lung cancer (SPLC).
Elderly with NSCLC have lower incidence of esophagitis, can tolerate aggressive radiation therapy.
A new tool may enable oncologists to deliver radiation therapy targeted to a tumor's biology and radiosensitivity, similar to how anticancer agents target specific tumor mutation-affected gene pathways.
A recent paper on the future of radiation oncology reports on the trend toward a greater role for shared decision making and patient-reported outcomes, such as the interrelated benchmarks of patient satisfaction, engagement, and treatment-plan adherence.
A growing proportion of cancer patients are elderly—creating a demographic shift with important implications for cancer care, including radiotherapy. Integrating geriatric care into oncology nursing has never been more important.
Side effects experienced with extremely hypofractionated treatment for intermediate-risk prostate cancer were comparable to those of conventional radiation therapy at 2 years after treatment.
Disease-specific mortality rates for men with prostate cancer are comparable for 3 treatment options: active surveillance, radical prostatectomy, and external-beam radiotherapy.
Novel technique uses injected microbubbles for dosimetry in radiation therapy in patients with cancer.
Skilled radiologists see abnormalities immediately, and researchers want to learn how they do it.
Postmastectomy pain syndrome (PMPS) is a debilitating late effect of surgery and radiation therapy for breast cancer.
Chemoradiation Combination Could Preserve Larynx in Patients With Laryngeal and Hypolaryngeal Cancer
Researchers assessed the rates of laryngeal preservation and laryngectomy-free survival in patients with laryngeal or hypopharyngeal cancer who received the monoclonal antibody cetuximab and radiation therapy or radiation therapy alone.
As salvage radiotherapy (SRT) outcomes may be affected by factors associated with prostatectomy findings, they may be positively affected when used at lower prostate-specific antigen (PSA) levels.
Preliminary results of a prospective, phase II trial show that once-daily accelerated partial breast irradiation (APBI) effectively prevented recurrence of cancer in the treated breast at a median 34 months after treatment.
Sleep patterns and habits should be a part of oncology nurses' routine patient assessment, as sleep disorders can be a significant challenge for cancer patients undergoing radiation therapy.
Laser heat may soon be an option to treat prostate cancer. Focal laser ablation has been found both feasible and safe in men with intermediate risk prostate cancer.
Surgery for early stage small cell lung cancer (SCLC) is rarely used. However, results from a population-based database has shown surgery with adjuvant chemotherapy with or without radiation for node-negative SCLC was associated with better survival compared with concurrent chemoradiation, according to a presentation at the 2016 ASCO Annual Meeting.
Combining radiation treatments with a new generation of immunotherapies is showing promise in the treatment of melanoma, according to a recent review.
Patients with stage IIA testicular cancer gain a survival advantage from treatment with radiation therapy compared with chemotherapy.
Increased Risk of Noncancer Deaths Associated with Stereotactic Body Radiation Therapy for Lung Cancer
High doses of SBRT, particularly to the left atrium of the heart and the superior vena cava, are associated with a small but increased risk of death from noncancer causes in patients with early stage NSCLC.
Adding an immune system-strengthening compound to radiation therapy can extend the immune response that the radiation therapy induces, so that both irradiated tumor sites and tumors outside the radiation field are affected.
Delayed radiation therapy (RT) after surgery significantly increased the risk of recurrent disease in women treated for very early breast cancer.
Longer survival was achieved with stereotactic radiosurgery (SRS) alone than with whole-brain radiation therapy (WBRT) in patients with fewer than 4 brain metastases from NSCLC or breast cancer.
The addition of chemotherapy to radiation therapy prolonged survival in adults with grade 2 glial brain tumors.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer tumors with fewer side effects; however, escalating the dose of radiation may not help patients with localized prostate cancer in the long term.
Nasal spray effectively relieves intense breakthrough pain associated with radiotherapy planning and treatment.
A new clinical trial aims to apply advanced image analysis techniques to 4D CT scans. Already a standard step in targeting lung cancer radiotherapy, the trial seeks to use the scans map areas of lung function without additional testing.
With long-term follow-up, letrozole can be safely administered concomitantly with adjuvant breast radiotherapy in postmenopausal patients with stage 1 to 2 breast cancer.
Radiotherapy is the most effective single modality for local control of Hodgkin lymphoma. Involved site radiotherapy is a recent innovation intended to reduce the risk of late effects—an urgent goal, particularly for adolescent and young adult patients.
A healthy immune system may be the key to effective radiation therapy for cancer patients.
Low-income women in Medicaid expansion states in the United States are more likely to undergo breast cancer screening than those in nonexpansion states, according to a study presented at RSNA 2015.
American College of Radiology (ACR) Releases Updated Appropriateness Criteria, Including 3 New Criteria
American College of Radiology updated its Appropriateness Criteria for 19 topics, including 3 new criteria. These guidelines assist clinicians in the most efficacious use of radiology.
Guidelines and novel approaches are helping clinicians to more effectively manage this debilitating side effect of radiation treatment for cancer.
The first study to examine the effects of combined radiation and chemotherapy on the healthy brain tissue of glioblastoma patients has revealed specific structural brain changes.
Variation in Medicare reimbursement for radiation therapy not attributed to patient or cancer characteristics
Differences in radiation therapy costs for Medicare patients often have little to do with patient specifics, researchers found.
The first test that analyzes the sensitivity of tumors to radiation therapy has been developed.
Two studies show benefits for hypofractionated versus conventionally fractionated whole-breast irradiation.
It is important that patients are advised early about the effect radiotherapy toxicity can have on their sexual anatomy and overall sexual health.
For patients with radiation-induced xerostomia, ALTENS may reduce symptom burden with less side effects than current standard treatment.
New templates from the American Society of Clinical Oncology (ASCO) will augment successful cancer survivorship care planning. But a stronger effort toward implementation is still needed.
Women with luminal A subtype breast cancer, especially those older than 60 years, may not need radiation treatment if they are already taking hormone therapy.
A new role for conformal radiotherapy is evolving. Targeted treatment can offer effective palliative management of pain and other side effects of cancer.
Erythropoietin plus radiation does not improve local-regional control in anemic patients with head and neck cancer
The addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma (HNSCC) who receive radiation therapy.
Two case studies have described what is believed to be the first reported successful use of stereotactic body radiation therapy for an oft-deadly kidney cancer complication.
The use of 3D printing to construct devices of varied sizes and shapes could become a powerful tool in customizing interventional radiology treatments to individual patient needs.
Interstitial lung disease appears to be a risk factor for radiation pneumonitis, a potentially life-threatening adverse effect of radiotherapy to the chest and thorax.
Therapy dogs improve the emotional well-being of some patients with cancer who are undergoing concomitant chemotherapy and radiotherapy.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
The effectiveness of radiation therapy used to treat head and neck cancer could depend in part on clinician experience, according to a new study.
An interventional x-ray guidance device approved by the U.S. Food and Drug Administration in 2013 may have the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy for liver cancer.
Researchers have developed a technology that improves the detection of tumors during radiation therapy for early stage lung cancer. It uses standard radiography machines and improves their images through a software approach.
Psychosocial decline occurs in an estimated one-third of patients undergoing radiotherapy for cancer. These declines may sometimes be ameliorated by vigilant recognition of the need to refer patients for psychosocial support interventions.
Invisible tattoos preferable option to mark where a patient with breast cancer should receive radiotherapy during sessions.
For patients with schizophrenia and breast cancer, initial radical surgery without adjuvant radiation therapy may be preferred.
The addition of chest radiation reduces recurrence rate and, improves survival when added to chemo in extensive stage small-cell lung cancer.
For patients with small cell lung cancer, chest radiotherapy increases survival, decreases recurrence
Advanced small cell lung cancer patients experienced prolonged survivalafter being treated prophylactic cranial radiotherapy.
High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.
Researchers have designed a method that increase the radiotherapy dose administered to patients with lung cancer.
Breast cancer screening is once again controversial. In this editorial, the author discusses new research demonstrating the effectiveness of an MRI imaging technique called first postcontrast subtracted T1-weighted image (FAST).
Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.
A new radiation technique appears to target tumor cells, leaving healthy cells unharmed, according to a new study in mice. The technique, known as FLASH, was developed by researchers at the Institute Curie in Paris, France.
What is the best approach to learning more about the field of Radiation Oncology?
Children who undergo repeated complex imaging tests that deliver higher doses of radiation may have a slightly increased lifetime risk of cancer, according to new research.
A multi-institutional, randomized phase III trial of fractionation in locally advanced head and neck cancer demonstrated improved local-regional control and improved overall survival with no increase in late toxicity with hyperfractionated radiation therapy.
In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy were cancer-free 28 months after treatment. Side effects typical of standard radiation were also reduced in some cases.
Hyperfractionated radiation therapy may increase local-regional control for patients with head and neck cancer
An old idea of retreating lung tumors with radiation is new again, especially with the technological advances seen in radiation oncology over the last decade.
Young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally recommended, according to new research.
The use of adjuvant radiation therapy in the treatment of endometrial cancer is detailed in a new guideline issued by the American Society of Radiation Oncology (ASTRO).
Sexual dysfunction is a common and distressing side effect of prostate cancer treatment. Two new reports from randomized clinical trials offer mixed results for adjuvant pharmacotherapy intended to prevent erectile dysfunction in men undergoing radiotherapy for prostate cancer.
Playing an active role in their radiation treatment decisions leaves patients with cancer feeling more satisfied with their care, and may even relieve psychologic distress around the experience, researchers reported.
This fact sheet examines radiation therapy, including forms of administration and potential side effects of treatment.
Reductions seen in locoregional recurrence, overall recurrence, and breast cancer mortality when radiotherapy is employed after mastectomy and axillary dissection.
Although uncommon, this side effect of radiation with adjuvant drug therapy is unpredictable, sometimes delayed, and can occur with administration of antibiotics and other drugs as well as chemotherapy.
Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control with minimal late toxicity.
Soy and soy isoflavones are alleviating skin and lung toxicities from thoracic radiotherapy in preclinical study models; however, researchers stress the need for further studies.
Patients with head and neck cancer who are treated with an advanced form of radiation therapy may experience fewer side effects and be less likely to die from their disease than patients who receive standard radiation therapy.
Respiratory motion management reduces radiation exposure to nontarget tissues in patients undergoing treatment of cancers in the chest and abdomen.
Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services.
Serum levels of the interleukin-6 family cytokine leukemia inhibitory factor (LIF) are higher in patients who did not respond to radiation therapy, according to new research.
Many larger-chested women develop moist desquamation under their breasts and are treated with Domeboro solution and air exposure. Are there any better methods for treating this condition?
Despite long-running evidence demonstrating that a single session of radiotherapy provides just as much pain relief to patients with terminal cancer as multiple treatments, the method has yet to be adopted into routine practice.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|